Scarica l'app Stockscreener
0.00
100.00%
-2.38
Dopo l'orario di chiusura:
2.34
2.34
+
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SAVA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Cassava Sciences Inc Borsa (SAVA) Ultime notizie
Energy Moves: What is Cassava Sciences Inc Equity Warrants book value per share - baoquankhu1.vn
SAVA PE Ratio & Valuation, Is SAVA Overvalued - Intellectia AI
ETF Watch: What are the future prospects of Cassava Sciences Inc Equity WarrantPortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Cassava Sciences, Inc. Common Stock (FLNA) Competitors - Meyka
Cassava Sciences says DOJ has closed probe into allegations around its Alzheimer’s program - MSN
Cassava Sciences Inc Share PriceShare CFDs - FOREX.com
FOMO Trade: Does Cassava Sciences Inc Equity Warrant offer margin of safety2026 Key Highlights & Expert Approved Momentum Ideas - baoquankhu1.vn
Trading Recap: Is Cassava Sciences Inc Equity Warrant subject to activist investor interest2026 Sentiment & Daily Stock Trend Watchlist - baoquankhu1.vn
Block Trades: Does Cassava Sciences Inc Equity Warrant have pricing powerMarket Sentiment Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail
Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SAVA * | US14817C1071 - marketscreener.com
FLNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cassava Sciences Posts Earnings, Beats Estimates - National Today
Cassava Sciences (NASDAQ:SAVA) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Filana Therapeutics (NASDAQ: SAVA) pivots to TSC epilepsy amid FDA clinical hold - Stock Titan
Total equity of Cassava Sciences, Inc. – BMV:FLNA - TradingView
Average basic shares outstanding of Cassava Sciences, Inc. – BMV:FLNA - TradingView
Cassava Sciences, Inc. Cash Flow – BMV:FLNA - TradingView
Price to book ratio of Cassava Sciences, Inc. – BMV:FLNA - TradingView
Free cash flow per share of Cassava Sciences, Inc. – BMV:FLNA - TradingView
Long term debt to total equity ratio of Cassava Sciences, Inc. – BMV:FLNA - TradingView
Cassava Sciences, Inc. Earnings and Revenue – BMV:FLNA - TradingView
Cassava Sciences, Inc. Balance Sheet – BMV:FLNA - TradingView
ETFs Investing in Cassava Sciences, Inc. Stocks - TradingView
FLNA Forecast — Price Target — Prediction for 2027 - TradingView
Filana Therapeutics (NASDAQ: FLNA) pivots to TSC epilepsy amid $91M loss - Stock Titan
Biotech that ditched Alzheimer's drug pivots to epilepsy, slashes R&D 62% - Stock Titan
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire
Rate Cut: Can Cassava Sciences Inc beat the S P 500Global Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
FLNA Stock Price and Chart — NASDAQ:FLNA - TradingView
Two new option listings and one option delisting on March 11th - TipRanks
Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker - The Globe and Mail
Filana Therapeutics, Inc. will Change its Ticker to FLNA from SAVA - marketscreener.com
Cassava Sciences, Inc. will Change its Ticker to FLNA from SAVA - marketscreener.com
Cassava Sciences, Inc. has Changed its Name to Filana Therapeutics, Inc - marketscreener.com
Investors Purchase Large Volume of Cassava Sciences Call Options (NASDAQ:SAVA) - MarketBeat
Filana Therapeutics (NASDAQ: FLNA) adopts new name and FLNA ticker - Stock Titan
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc. - cassavasciences.com
Cassava Sciences : SAVA Corp 4Presentation rebrandas of Mar 09 2026 - marketscreener.com
Aug Ideas: Will Cassava Sciences Inc outperform small cap indexesLong Setup & Daily Chart Pattern Signals - baoquankhu1.vn
Cassava Sciences (NASDAQ:SAVA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Cassava Sciences Says DOJ Has Closed Probe Into Allegations Around Its Alzheimer’s Program - Stocktwits
Momentum Shift: What dividend growth rate does Cassava Sciences Inc Equity Warrant offerJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Cassava Sciences (SAVA) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
SAVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cassava Sciences (NASDAQ:SAVA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
SAVA SEC FilingsCassava Sciences 10-K, 10-Q, 8-K Forms - Stock Titan
Cassava Sciences Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Dow Update: Can Cassava Sciences Inc beat the S P 500July 2025 PreEarnings & Free Long-Term Investment Growth Plans - baoquankhu1.vn
SAVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MSN Money - MSN
Cassava Sciences says US DOJ has closed investigation into company - Classic Rock 103.5 WIMZ
DOJ closes inquiry into Cassava Sciences over research misconduct By Investing.com - Investing.com Canada
JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B - Stocktwits
3.80%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):